UniCredit Call 22 FRE 19.03.2025/ DE000HD4M3E1 /
20.12.2024 20:57:01 | Изменение+0.01 | Бид22:00:28 | Предложение22:00:28 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
2.93EUR | +0.34% | - Величина цены спроса: - |
- Величина цены предложения: - |
FRESENIUS SE+CO.KGAA... | 22.00 - | 19.03.2025 | Call |
GlobeNewswire
24.04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23.04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23.02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04.09.2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31.08.2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница